The importance of matrix metalloproteinase-3 in respiratory disorders

The matrix metalloproteinases (MMPs) encompass a family of zinc-dependent endopeptidases that are secreted into the extracellular environment or remain bound to the cell surface. While MMPs were initially identified based on their ability to degrade collagen and other components of the extracellular matrix, recent studies indicate that their non-degradative functions are physiologically paramount. In particular, MMPs are now known to participate in diverse physiological processes that control key aspects of inflammatory and immune responses and neoplasia, in part by selective triggering of cellular signaling pathways via limited proteolytic processing of extracellular and membrane-associated proteins, including cytokines and cell surface receptors. Herein, we focus on the unique roles of MMP-3 (stromelysin-1) in acute lung injury and repair, pulmonary fibrosis, and lung cancer.

[1]  M. Balaan,et al.  Acute Respiratory Distress Syndrome , 2016, Critical care nursing quarterly.

[2]  V. Ranieri,et al.  Novel approaches to minimize ventilator-induced lung injury , 2015, Current opinion in critical care.

[3]  Kyung-Ja Cho,et al.  Epithelial-Mesenchymal Transition , 2014, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[4]  D. Thickett,et al.  Epithelial–mesenchymal transition in lung development and disease: does it exist and is it important? , 2013, Thorax.

[5]  K. Rabe,et al.  Management of non-small-cell lung cancer: recent developments , 2013, The Lancet.

[6]  R. Khokha,et al.  Metalloproteinases and their natural inhibitors in inflammation and immunity , 2013, Nature Reviews Immunology.

[7]  A. Ciapponi,et al.  High versus low positive end-expiratory pressure (PEEP) levels for mechanically ventilated adult patients with acute lung injury and acute respiratory distress syndrome. , 2013, The Cochrane database of systematic reviews.

[8]  Maria João M Bugalho,et al.  RAC1b overexpression in papillary thyroid carcinoma: a role to unravel. , 2013, European journal of endocrinology.

[9]  Anthony J Alberg,et al.  Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. , 2013, Chest.

[10]  Brent S. Pedersen,et al.  Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis , 2013, Nature Genetics.

[11]  D. Radisky,et al.  Matrix compliance regulates Rac1b localization, NADPH oxidase assembly, and epithelial–mesenchymal transition , 2012, Molecular biology of the cell.

[12]  G. Downey,et al.  IL‐1β enhances cell adhesion to degraded fibronectin , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  D. Radisky,et al.  Matrix Metalloproteinase Induction of Rac1b, a Key Effector of Lung Cancer Progression , 2012, Science Translational Medicine.

[14]  D. Radisky,et al.  Involvement of hnRNP A1 in the matrix metalloprotease‐3‐dependent regulation of Rac1 pre‐mRNA splicing , 2012, Journal of cellular biochemistry.

[15]  Arthur S Slutsky,et al.  Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .

[16]  T. Maher Idiopathic pulmonary fibrosis: pathobiology of novel approaches to treatment. , 2012, Clinics in chest medicine.

[17]  Xue-qing Xu,et al.  Association between Polymorphisms in the Promoter Regions of Matrix Metalloproteinases (MMPs) and Risk of Cancer Metastasis: A Meta-Analysis , 2012, PloS one.

[18]  Moisés Selman,et al.  Idiopathic pulmonary fibrosis , 2011, The Lancet.

[19]  Michael J. Cronce,et al.  Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition , 2011, Proceedings of the National Academy of Sciences.

[20]  D. Radisky,et al.  Cardiovascular , Pulmonary , and Renal Pathology Matrix Metalloproteinase 3 Is a Mediator of Pulmonary Fibrosis , 2011 .

[21]  G. Downey Resolving the scar of pulmonary fibrosis. , 2011, The New England journal of medicine.

[22]  Thomas A. Wynn,et al.  Integrating mechanisms of pulmonary fibrosis , 2011, The Journal of experimental medicine.

[23]  R. D. du Bois,et al.  Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium. , 2011, Chest.

[24]  Ivana V. Yang,et al.  A common MUC5B promoter polymorphism and pulmonary fibrosis. , 2011, The New England journal of medicine.

[25]  C. Owen,et al.  Matrix metalloproteinases: all the RAGE in the acute respiratory distress syndrome. , 2011, American journal of physiology. Lung cellular and molecular physiology.

[26]  M. Matthay,et al.  Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells. , 2011, American journal of physiology. Lung cellular and molecular physiology.

[27]  Takeshi Johkoh,et al.  American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .

[28]  P. Lansdorp,et al.  Ancestral Mutation in Telomerase Causes Defects in Repeat Addition Processivity and Manifests As Familial Pulmonary Fibrosis , 2011, PLoS genetics.

[29]  M. Matthay,et al.  The acute respiratory distress syndrome: pathogenesis and treatment. , 2011, Annual review of pathology.

[30]  Ingebrigt Sylte,et al.  Regulation of matrix metalloproteinase activity in health and disease , 2011, The FEBS journal.

[31]  X. Puente,et al.  Absence or inhibition of matrix metalloproteinase-8 decreases ventilator-induced lung injury. , 2010, American journal of respiratory cell and molecular biology.

[32]  G. Downey,et al.  Importance of Protein-tyrosine Phosphatase-α Catalytic Domains for Interactions with SHP-2 and Interleukin-1-induced Matrix Metalloproteinase-3 Expression* , 2010, The Journal of Biological Chemistry.

[33]  D. Radisky,et al.  The 19-Amino Acid Insertion in the Tumor-associated Splice Isoform Rac1b Confers Specific Binding to p120 Catenin* , 2010, The Journal of Biological Chemistry.

[34]  Matthias Briel,et al.  Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. , 2010, JAMA.

[35]  E. White,et al.  Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis. , 2010, American journal of respiratory and critical care medicine.

[36]  G. Perkins,et al.  Salbutamol up-regulates matrix metalloproteinase-9 in the alveolar space in the acute respiratory distress syndrome , 2009, Critical care medicine.

[37]  W. Seeger,et al.  WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. , 2009, The Journal of clinical investigation.

[38]  D. Radisky,et al.  Change in cell shape is required for matrix metalloproteinase‐induced epithelial‐mesenchymal transition of mammary epithelial cells , 2008, Journal of cellular biochemistry.

[39]  Robert A. Weinberg,et al.  Twisted epithelial–mesenchymal transition blocks senescence , 2008, Nature Cell Biology.

[40]  W. Seeger,et al.  Functional Wnt Signaling Is Increased in Idiopathic Pulmonary Fibrosis , 2008, PloS one.

[41]  Ping Yang,et al.  Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. , 2008, Mayo Clinic proceedings.

[42]  D. Radisky,et al.  Matrix metalloproteinase-induced fibrosis and malignancy in breast and lung. , 2008, Proceedings of the American Thoracic Society.

[43]  Naftali Kaminski,et al.  MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis , 2008, PLoS medicine.

[44]  A. Gutiérrez-Fernández,et al.  Lack of matrix metalloproteinase-9 worsens ventilator-induced lung injury. , 2008, American Journal of Physiology - Lung cellular and Molecular Physiology.

[45]  N. Kaminski,et al.  Idiopathic Pulmonary Fibrosis: Aberrant Recapitulation of Developmental Programs? , 2008, PLoS medicine.

[46]  S. Jaber,et al.  Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. , 2008, JAMA.

[47]  K. Kuwano,et al.  Dual-immunohistochemistry provides little evidence for epithelial–mesenchymal transition in pulmonary fibrosis , 2008, Histochemistry and Cell Biology.

[48]  C. Libert,et al.  Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation , 2007, Journal of leukocyte biology.

[49]  J. Varani,et al.  Matrix metalloproteinase-3 (stromelysin-1) in acute inflammatory tissue injury. , 2007, Experimental and molecular pathology.

[50]  Chao Xing,et al.  Adult-onset pulmonary fibrosis caused by mutations in telomerase , 2007, Proceedings of the National Academy of Sciences.

[51]  P. Lansdorp,et al.  Telomerase mutations in families with idiopathic pulmonary fibrosis. , 2007, The New England journal of medicine.

[52]  Andrew J. Ewald,et al.  Matrix metalloproteinases and the regulation of tissue remodelling , 2007, Nature Reviews Molecular Cell Biology.

[53]  S. Gayther,et al.  Molecular profiling of cervical cancer progression , 2007, British Journal of Cancer.

[54]  Changqing Zeng,et al.  Haplotypes in Matrix Metalloproteinase Gene Cluster on Chromosome 11q22 Contribute to the Risk of Lung Cancer Development and Progression , 2006, Clinical Cancer Research.

[55]  A. Lièvre,et al.  Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma , 2006, BMC Cancer.

[56]  G. Oster,et al.  Incidence and prevalence of idiopathic pulmonary fibrosis. , 2006, American journal of respiratory and critical care medicine.

[57]  Gordon R Bernard,et al.  Comparison of two fluid-management strategies in acute lung injury. , 2006, The New England journal of medicine.

[58]  J. Keski‐Oja,et al.  Epilysin (MMP-28) induces TGF-β mediated epithelial to mesenchymal transition in lung carcinoma cells , 2006, Journal of Cell Science.

[59]  D. Brenner,et al.  Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis , 2006, Hepatology.

[60]  T. Standiford,et al.  Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury. , 2006, Human pathology.

[61]  J. Minna,et al.  Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines. , 2006, Cancer research.

[62]  G. Cavet,et al.  Epithelial versus Mesenchymal Phenotype Determines In vitro Sensitivity and Predicts Clinical Activity of Erlotinib in Lung Cancer Patients , 2005, Clinical Cancer Research.

[63]  E. Brown,et al.  Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. , 2005, Cancer research.

[64]  R. Veldhuizen,et al.  Differential response of TIMP-3 null mice to the lung insults of sepsis, mechanical ventilation, and hyperoxia. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[65]  D. Albertson,et al.  Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability , 2005, Nature.

[66]  W. Guo,et al.  Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. , 2004, Carcinogenesis.

[67]  Radovan Dvorsky,et al.  Alternative Splicing of Rac1 Generates Rac1b, a Self-activating GTPase* , 2004, Journal of Biological Chemistry.

[68]  Arthur S Slutsky,et al.  Biotrauma hypothesis of ventilator-induced lung injury. , 2004, American journal of respiratory and critical care medicine.

[69]  John G. Collard,et al.  Tumor-related Alternatively Spliced Rac1b Is Not Regulated by Rho-GDP Dissociation Inhibitors and Exhibits Selective Downstream Signaling* , 2003, Journal of Biological Chemistry.

[70]  S. Chakraborti,et al.  Regulation of matrix metalloproteinases: An overview , 2003, Molecular and Cellular Biochemistry.

[71]  J. Mullol,et al.  Transforming growth factor-beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. , 2003, American journal of respiratory and critical care medicine.

[72]  W. Parks,et al.  Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. , 2003, The American journal of pathology.

[73]  V. Lagente,et al.  Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients , 2003, Critical care medicine.

[74]  Naftali Kaminski,et al.  Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[75]  B. Fingleton,et al.  Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.

[76]  L. Van Aelst,et al.  The role of Rho GTPases in disease development. , 2002, Gene.

[77]  E. Sahai,et al.  RHO–GTPases and cancer , 2002, Nature Reviews Cancer.

[78]  John G. Collard,et al.  Regulation of the cytoskeleton by Rho-family GTPases: implications for tumour cell invasion. , 2001, Seminars in cancer biology.

[79]  D. Bar-Sagi,et al.  Ras and Rho GTPases A Family Reunion , 2000, Cell.

[80]  E. Lengyel,et al.  Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b , 2000, Oncogene.

[81]  D. Schoenfeld,et al.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.

[82]  J. Foidart,et al.  Demonstration in vivo that stromelysin-3 functions through its proteolytic activity , 2000, Oncogene.

[83]  B. Fingleton,et al.  Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. , 2000, The Journal of clinical investigation.

[84]  P. Jordan,et al.  Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors , 1999, Oncogene.

[85]  Z. Werb,et al.  The Significance of Matrix Metalloproteinases during Early Stages of Tumor Progression a , 1998, Annals of the New York Academy of Sciences.

[86]  Z. Werb,et al.  Matrix Metalloproteinase Stromelysin-1 Triggers a Cascade of Molecular Alterations That Leads to Stable Epithelial-to-Mesenchymal Conversion and a Premalignant Phenotype in Mammary Epithelial Cells , 1997, The Journal of cell biology.

[87]  P. Suter,et al.  Matrix metalloproteinases and TIMP in acute respiratory distress syndrome. , 1996, American journal of respiratory and critical care medicine.

[88]  S. Rosselot Idiopathic pulmonary fibrosis. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[89]  R. Khokha,et al.  Tissue inhibitor of metalloproteinases 3 regulates resolution of inflammation following acute lung injury. , 2010, The American journal of pathology.

[90]  L. Kruidenier,et al.  Myofibroblast matrix metalloproteinases activate the neutrophil chemoattractant CXCL7 from intestinal epithelial cells. , 2006, Gastroenterology.

[91]  P. Carmeliet,et al.  Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice. , 2005, The American journal of pathology.

[92]  Arthur S Slutsky,et al.  Ventilator-induced lung injury: from the bench to the bedside , 2005, Intensive Care Medicine.

[93]  George Stoica,et al.  Expression of MMP2, MMP9 and MMP3 in Breast Cancer Brain Metastasis in a Rat Model , 2005, Clinical & Experimental Metastasis.

[94]  Michael J. Green,et al.  Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. , 2003, Rheumatology.

[95]  J. Mullol,et al.  Transforming growth factor-beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. , 2003, American journal of respiratory and critical care medicine.

[96]  S. Weiss,et al.  Role of stromelysin 1 and gelatinase B in experimental acute lung injury. , 2001, American journal of respiratory cell and molecular biology.

[97]  Z. Werb,et al.  How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.

[98]  B. Boyan,et al.  The First Stage of Transforming Growth Factor β1 Activation is Release of the Large Latent Complex from the Extracellular Matrix of Growth Plate Chondrocytes by Matrix Vesicle Stromelysin-1 (MMP-3) , 2001, Calcified Tissue International.